The third patient of leukemia was declared completely cured by the experimental drug

Texas: A third person in the final stages of leukemia has been cured of a malignant cancer that had failed all previous treatments.

A good news has come from America, in which the blood cancer of the third patient has been completely eradicated by the pill called ‘Revunib’. The long-awaited clinical trial has experts excited. This research has been done by Dr. Ghiyas Isa, who is a leukemia specialist at the University of Texas.

Doctors have targeted acute myeloid leukemia (AML), which affects the bone marrow where blood cells are produced. From there, the cancer continues to make abnormal and dangerous blood cells and deliver them to the body, and the patient reaches the fatal AML.

In this targeted therapy, a special protein called menin is inhibited by ‘ReVonib’. In this way, cells damaged by leukemia begin to return to normal. Menin is part of a complex process that leukemia hijacks and destroys remaining healthy cells. In this way, the blood of the patient is filled with infected cancer cells.

According to experts, so far 18 people have benefited from it, but in three patients, no relapse of leukemia was seen. In an initial trial, 53 percent of patients who had not previously been treated with Revanib worked. 30% of these patients had no cancer at all.

However, doctors insist that ‘ReVonib’ is not a cure for every patient and only those suffering from genetic defects or chromosomal abnormalities can benefit. Such patients have become resistant to many drugs and that is why ‘Revunib’ has proved to be an excellent drug.